FDA last week approved the first blood test to help assess Alzheimer’s disease and other causes of cognitive decline in primary care settings, in today’s bite-sized hospital and health industry news from Maryland, Pennsylvania, and Washington. Maryland: FDA has approved the first blood-based biomarker test to help providers assess patients for Alzheimer’s disease and other […]
